Platelet-Rich Plasma for the Treatment of Atopic Dermatitis: A Literature Review

Platelet-rich plasma (PRP) shows promise as an adjuvant therapy for moderate to severe atopic dermatitis (AD), potentially enhancing the effectiveness of existing treatments and improving patients' quality of life. A review of seven studies indicates that PRP, administered in injectable or topical forms, can significantly reduce inflammation, promote healing, and improve clinical symptoms and patient satisfaction, with mild side effects such as pain and ecchymosis. PRP is also safe for use in pregnant and breastfeeding women. However, the heterogeneity in PRP preparation methods suggests a need for further research with larger, standardized protocols to confirm these findings.